Prognostic Stage IIA Breast Cancer AJCC v8 Recruiting Phase 2 Trials for Abemaciclib (DB12001)

Also known as: Prognostic Stage 2A Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0109633 (Prognostic Stage IIA Breast Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03979508Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast CancerTreatment